(Q57225370)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

0 references

C H Chesnut

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

N H Bell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

H K Genant

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

S T Harris

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

F R Singer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

J L Stock

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

R A Yood

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

P D Delmas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

language of work or name

English

0 references

publication date

1 August 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

22 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

144-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Evaluation of two food frequency methods of measuring dietary calcium intake.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

In vitro comparability of dual energy X-ray absorptiometry (DEXA) bone densitometers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Testing for qualitative interactions between treatment effects and patient subsets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Testing the statistical certainty of a response to increasing doses of a drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Long-term calcitonin therapy in postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

The effect of hypoparathyroidism on the aging skeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Diminished rates of bone formation in normal black adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Detection of prefracture spinal osteoporosis using bone mineral absorptiometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Lifetime fracture risk: an approach to hip fracture risk assessment based on bone mineral density and age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Pre-existing fractures and bone mass predict vertebral fracture incidence in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980134-X

10.1016/S0002-9343(99)80134-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7625419%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference